1
Douglas Hole, Christopher C Miller: Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma. Pulmonox Technologies Corporation, Sidley Austin, May 12, 2009: US07531133 (20 worldwide citation)

A method of reducing pathogens in blood by exposure to a nitric oxide containing gas in an extracorporeal circuitry is provided. The method includes: obtaining blood from a mammal or a blood source, separating the blood into plasma and blood cells, exposing the plasma to nitric oxide containing gas, ...


2
Douglas Hole, Christopher C Miller: Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma. Sidley Austin Brown & Wood, January 18, 2007: US20070014688-A1

A method of reducing pathogens in blood by exposure to a nitric oxide containing gas in an extracorporeal circuitry is provided. The method includes: obtaining blood from a mammal or a blood source, separating the blood into plasma and blood cells, exposing the plasma to nitric oxide containing gas, ...


3
Bryan Perry, Christopher Miller, Douglas Hole: Use of aerosolized compounds in the treatment of exercise induced pulmonary hemorrhage in an equine. Kevin D McCarthy, Roach Brown McCarthy & Gruber PC, April 17, 2003: US20030070674-A1

The administration of aerosolized nitric oxide donors or type V phosphodiesterase inhibitor in controlled doses to horses during high intensity exercise is described. Aerosolized nitric oxide donors (in conjunction with intravenous type V phosphodiesterase inhibitor) and type V phosphodiesterase inh ...